These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 30598575)

  • 1. Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy.
    Li H; Huang MH; Jiang JD; Peng ZG
    World J Gastroenterol; 2018 Dec; 24(47):5297-5311. PubMed ID: 30598575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What Are the Benefits of a Sustained Virologic Response to Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection?
    Ioannou GN; Feld JJ
    Gastroenterology; 2019 Jan; 156(2):446-460.e2. PubMed ID: 30367836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced immune responses, PI3K/AKT and JAK/STAT signaling pathways following hepatitis C virus eradication by direct-acting antiviral therapy among Egyptian patients: a case control study.
    Ramadan HK; Badr G; Ramadan NK; Sayed A
    Pathog Dis; 2021 Mar; 79(3):. PubMed ID: 33524139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-Acting Antivirals.
    Debes JD; van Tilborg M; Groothuismink ZMA; Hansen BE; Schulze Zur Wiesch J; von Felden J; de Knegt RJ; Boonstra A
    Gastroenterology; 2018 Feb; 154(3):515-517.e3. PubMed ID: 29102620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rewiring Host Signaling: Hepatitis C Virus in Liver Pathogenesis.
    Virzì A; Roca Suarez AA; Baumert TF; Lupberger J
    Cold Spring Harb Perspect Med; 2020 Jan; 10(1):. PubMed ID: 31501266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Path to Cancer and Back: Immune Modulation During Hepatitis C Virus Infection, Progression to Fibrosis and Cancer, and Unexpected Roles of New Antivirals.
    Debes JD; de Knegt RJ; Boonstra A
    Transplantation; 2017 May; 101(5):910-915. PubMed ID: 28045877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis.
    Khatun M; Ray RB
    Cells; 2019 Oct; 8(10):. PubMed ID: 31615075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals.
    Perez S; Kaspi A; Domovitz T; Davidovich A; Lavi-Itzkovitz A; Meirson T; Alison Holmes J; Dai CY; Huang CF; Chung RT; Nimer A; El-Osta A; Yaari G; Stemmer SM; Yu ML; Haviv I; Gal-Tanamy M
    PLoS Genet; 2019 Jun; 15(6):e1008181. PubMed ID: 31216276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent Hepatic Inflammation Plays a Role in Hepatocellular Carcinoma After Sustained Virological Response in Patients with HCV Infection.
    Nirei K; Kanda T; Nakamura H; Matsuoka S; Takayama T; Sugitani M; Moriyama M
    Int J Med Sci; 2018; 15(5):466-474. PubMed ID: 29559835
    [No Abstract]   [Full Text] [Related]  

  • 10. Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows.
    Guarino M; Sessa A; Cossiga V; Morando F; Caporaso N; Morisco F;
    World J Gastroenterol; 2018 Jun; 24(24):2582-2595. PubMed ID: 29962815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis in hepatitis C virus infection.
    Bantel H; Schulze-Osthoff K
    Cell Death Differ; 2003 Jan; 10 Suppl 1():S48-58. PubMed ID: 12655346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication.
    Motoyama H; Tamori A; Kubo S; Uchida-Kobayashi S; Takemura S; Tanaka S; Ohfuji S; Teranishi Y; Kozuka R; Kawamura E; Hagihara A; Morikawa H; Enomoto M; Murakami Y; Kawada N
    PLoS One; 2018; 13(3):e0194163. PubMed ID: 29534101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
    Meringer H; Shibolet O; Deutsch L
    World J Gastroenterol; 2019 Aug; 25(29):3929-3940. PubMed ID: 31413528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma recurrence in hepatitis C virus-related cirrhosis treated with direct-acting antivirals: a case-control study.
    Adhoute X; Penaranda G; Raoul JL; Sellier F; Castellani P; Oules V; Perrier H; Lefolgoc G; Pol B; Campanile M; Bayle O; Beaurain P; Monnet O; Bourlière M
    Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):368-375. PubMed ID: 29384796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents.
    Kanwal F; Kramer J; Asch SM; Chayanupatkul M; Cao Y; El-Serag HB
    Gastroenterology; 2017 Oct; 153(4):996-1005.e1. PubMed ID: 28642197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside.
    Rockey DC; Friedman SL
    Gastroenterology; 2021 Apr; 160(5):1502-1520.e1. PubMed ID: 33529675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma.
    Wirth TC; Manns MP
    Ann Oncol; 2016 Aug; 27(8):1467-74. PubMed ID: 27226385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response.
    Bruno S; Di Marco V; Iavarone M; Roffi L; Boccaccio V; Crosignani A; Cabibbo G; Rossi S; Calvaruso V; Aghemo A; Giacomelli L; Craxì A; Colombo M; Maisonneuve P
    Liver Int; 2017 Oct; 37(10):1526-1534. PubMed ID: 28418617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study.
    Ferrarese A; Germani G; Gambato M; Russo FP; Senzolo M; Zanetto A; Shalaby S; Cillo U; Zanus G; Angeli P; Burra P
    World J Gastroenterol; 2018 Oct; 24(38):4403-4411. PubMed ID: 30344424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary metabolomics of HCV patients with severe liver fibrosis before and during the sustained virologic response achieved by direct acting antiviral treatment.
    Biliotti E; Giampaoli O; Sciubba F; Marini F; Tomassini A; Palazzo D; Capuani G; Esvan R; Spaziante M; Taliani G; Miccheli A
    Biomed Pharmacother; 2021 Nov; 143():112217. PubMed ID: 34560544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.